Rapha Health System INC
Rapha Health System INC was paid $5.46M by Medicaid between Jan 2018 and Dec 2024, across 115 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoRAPHA HEALTH SYSTEM INC
FAYETTEVILLE, NC 28314
FAYETTEVILLE, NC 28314
33aNPI1275510695assigned 12/28/2005
33bProvider typePh.D. Medical Genetics
28Total paid$5.46M
24GClaims486,482
24DCodes billed115
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,865 | $340K | |
| 2019 | 48,297 | $637K | |
| 2020 | 53,690 | $689K | |
| 2021 | 73,092 | $849K | |
| 2022 | 86,817 | $908K | |
| 2023 | 90,335 | $974K | |
| 2024incomplete | 106,386 | $1.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 48,088 | 34,182 | $2.73M |
| 99199 | Unlisted special service, procedure or report | 17% | 147,572 | 91,206 | $948K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10.0% | 11,271 | 8,026 | $544K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.5% | 2,040 | 1,538 | $189K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.2% | 2,356 | 1,808 | $175K |
| 99401 | 2.6% | 7,198 | 5,133 | $141K | |
| 99406 | 2.0% | 11,055 | 8,940 | $111K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.9% | 613 | 134 | $103K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 6,364 | 4,336 | $63K |
| 99407 | <1% | 3,086 | 2,761 | $54K | |
| 93000 | <1% | 3,855 | 3,166 | $35K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 392 | 359 | $35K |
103 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 611 | $31K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,198 | $29K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 218 | $27K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 374 | $27K |
| 93923 | <1% | 517 | $22K | |
| 99385 | <1% | 224 | $20K | |
| 82962 | <1% | 10,241 | $19K | |
| 97760 | <1% | 1,208 | $12K | |
| 94010 | <1% | 830 | $12K | |
| 99442 | <1% | 282 | $10K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 573 | $10K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 562 | $10K |
| 99441 | <1% | 502 | $9K | |
| 95923 | <1% | 197 | $8K | |
| 99384 | <1% | 97 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 861 | $7K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 54 | $7K |
| 72100 | <1% | 433 | $7K | |
| 95117 | <1% | 1,153 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 452 | $6K |
| 90686 | <1% | 1,137 | $6K | |
| 96132 | <1% | 332 | $4K | |
| 93922 | <1% | 110 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 50 | $3K |
| 99386 | <1% | 27 | $3K | |
| 99490 | Ccm add 20min | <1% | 878 | $3K |
| 99383 | <1% | 38 | $2K | |
| 99051 | <1% | 114 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 987 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 681 | $1K |
| 96138 | <1% | 386 | $1K | |
| 94660 | <1% | 126 | $1K | |
| 3044F | <1% | 1,655 | $1K | |
| 99201 | <1% | 53 | $1K | |
| 74018 | <1% | 103 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,717 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 18 | $1K |
| 95921 | <1% | 44 | $974.95 | |
| 92546 | <1% | 26 | $937.65 | |
| 20610 | <1% | 37 | $704.24 | |
| 99408 | <1% | 29 | $703.40 | |
| 95927 | <1% | 14 | $664.92 | |
| 73560 | <1% | 49 | $593.95 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 3,528 | $519.72 |
| 92540 | <1% | 17 | $457.08 | |
| 93015 | <1% | 12 | $448.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,972 | $406.63 |
| J1815 | Injection, insulin, per 5 units | <1% | 1,841 | $385.77 |
| 90661 | <1% | 22 | $359.28 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 60 | $251.39 |
| 99495 | <1% | 27 | $219.03 | |
| 96127 | <1% | 52 | $179.34 | |
| 95922 | <1% | 14 | $175.85 | |
| 95943 | <1% | 13 | $120.80 | |
| 99497 | <1% | 14 | $94.38 | |
| 3046F | <1% | 80 | $80.07 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 49 | $35.35 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 37 | $34.95 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 37,609 | $22.89 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 25 | $22.27 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 21 | $21.16 |
| 3051F | <1% | 12 | $20.02 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 152 | $20.00 |
| 90688 | <1% | 15 | $16.67 | |
| 94760 | <1% | 193 | $4.14 | |
| 3079F | <1% | 10,682 | $2.87 | |
| 3074F | <1% | 9,844 | $2.68 | |
| 3078F | <1% | 5,944 | $1.63 | |
| 1159F | <1% | 3,009 | $1.36 | |
| 1160F | <1% | 3,079 | $1.35 | |
| 3075F | <1% | 4,896 | $1.34 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 345 | $1.28 |
| 3077F | <1% | 3,946 | $1.28 | |
| 3080F | <1% | 2,038 | $0.79 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 18 | $0.12 |
| 4004F | <1% | 12,126 | $0.02 | |
| 1036F | 0% | 25,769 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 19,670 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 17,241 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 176 | $0.00 |
| 1101F | 0% | 83 | $0.00 | |
| 99000 | 0% | 733 | $0.00 | |
| 3011F | 0% | 174 | $0.00 | |
| 3008F | 0% | 3,080 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 98 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 119 | $0.00 |
| 1034F | 0% | 869 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 843 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 48 | $0.00 |
| 1220F | 0% | 52 | $0.00 | |
| 1111F | 0% | 12 | $0.00 | |
| 4037F | 0% | 33 | $0.00 | |
| 3014F | 0% | 27 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 20,251 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 18,718 | $0.00 |
| 99072 | 0% | 445 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 214 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,811 | $0.00 |
| 4274F | 0% | 144 | $0.00 | |
| 3023F | 0% | 18 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 20 | $0.00 |
| 4025F | 0% | 33 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialUBA, DANIEL (OWNER, MD)
| Provider | Location | Paid |
|---|---|---|
| Rapha Urgent Care PLLC | Fayetteville, NC | $309K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.